Summary

The global Codonopsis Health Supplements market is projected to grow from US$ 88.50 million in 2025 to US$ 140 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Codonopsis Health Supplements are finished oral health or dietary supplement products intentionally formulated with Codonopsis species or compliant Codonopsis preparations as functional ingredients. The scope maps local regulatory equivalents rather than applying one jurisdiction’s terminology globally: China-regulated health foods, U.S. dietary supplements, European food supplements and equivalent regulated products in other markets are included when Codonopsis is deliberately incorporated into the finished formula. Typical commercial forms include capsules, tablets and pills, powders or granules, oral liquids and tinctures, measured beverage formats and other oral delivery forms; products may be single-Codonopsis formulas, multi-botanical combinations or hybrid formulas combining botanicals with vitamins, minerals or other active ingredients. The market is measured at the finished-product manufacturing stage, with volume standardized to retail packs and value based on producer-level finished-product selling value before downstream retail mark-ups, taxes and channel commissions.
Key Findings
Global sales volume reached 9.02 million retail packs in 2025, with producer ASP of about US$9.82 per pack
Capsules and softgels were the largest dosage-form segment in 2025 at 32%, while multi-botanical formulas represented 58%
Immune support was the largest primary consumer benefit in 2025 at 32%, followed by energy, fatigue and vitality support at 20%
The market remains a specialist botanical niche led by St. Francis Herb Farm and Sun Ten, with a broad international second tier
Global volume is modeled to reach 13.70 million retail packs by 2032 as hybrid formulas and convenient formats gain penetration
Market Trends
Codonopsis Health Supplements are shifting from a market centered on traditional herbal positioning toward a broader mix of standardized botanical formulas, practitioner products and consumer-oriented functional supplements. The most important structural change is the rising role of Codonopsis as one component within multi-botanical and hybrid formulations rather than as a stand-alone ingredient. This allows manufacturers to position Codonopsis within established consumer needs such as immune support, fatigue and vitality, digestive wellness, nutritional support and stress-related wellness without requiring Codonopsis itself to achieve the same consumer recognition as globally mainstream botanicals. Dosage-form diversification is reinforcing this transition: capsules, tablets, powders and liquids remain the commercial base, while measured beverages, sachets and chewable formats broaden convenience and accessibility. FDA guidance confirms that dietary supplements can legitimately take forms including tablets, capsules, gummies, liquids and powders, while European consumer research points to continuing innovation, e-commerce expansion and self-care as important forces shaping the wider supplement sector.
Market Dynamics
Drivers
The principal demand driver is the combination of preventive health behavior and established consumer acceptance of herbal and dietary supplements. In the 2026 AESGP European study, 55% of surveyed consumers purchased food supplements and 62% of users consumed them daily; overall health and immunity were leading motivations. These patterns are particularly relevant to Codonopsis because the current product portfolio is heavily exposed to immune, energy, fatigue and general wellness positioning. China adds a separate structural catalyst: Codonopsis was formally added in 2023 to the national list of substances traditionally used both as food and Chinese medicinal materials, increasing ingredient visibility and broadening the surrounding product-development ecosystem while maintaining separate rules for health-food applications. Growth is therefore supported by a larger supplement-consumption base, greater familiarity with botanical ingredients, continued functional formulation activity and broader availability through professional, specialist-retail and digital channels.
Restraints
The main restraint is that Codonopsis remains a specialist ingredient rather than a high-recognition global botanical category. Demand often depends on the attractiveness of the overall formula rather than explicit consumer pull for Codonopsis, leaving the ingredient exposed to substitution by other botanicals competing for similar immune, energy, vitality and adaptogenic positioning. Regulatory fragmentation also constrains international scalability. In the United States, structure-function and general-wellness claims must be truthful, substantiated and appropriately notified, and products cannot cross into disease-treatment claims without becoming subject to drug regulation. In China, Codonopsis may be used within the food framework under its food-medicine status, but health-food applications remain governed by health-food rules. These requirements limit the ability to deploy a single global claim architecture and increase formulation, labeling, evidence and regulatory costs for brands operating across multiple jurisdictions.
Opportunities
The strongest opportunity lies in increasing Codonopsis inclusion within multi-botanical and hybrid products rather than relying only on stand-alone Codonopsis supplements. Multi-botanical formulas already represent the dominant formula architecture, while hybrid formulas combining botanicals with vitamins, minerals or other functional ingredients are positioned to gain share through 2032. This structure allows Codonopsis to participate in larger functional categories even when consumers do not specifically search for the ingredient. Additional opportunity exists in convenient delivery formats, professional practitioner ranges, high-quality standardized extracts and contract manufacturing for brands that lack their own botanical production capabilities. China’s tightening manufacturing standards and clearer oversight of commissioned production are also likely to favor manufacturers that can provide formulation support, multi-format manufacturing, traceability, quality assurance and regulatory execution as an integrated service rather than competing solely on ex-factory price.
Challenges
The major operating challenge is converting traditional use and extensive botanical familiarity into reproducible modern products with consistent identity, composition and legally supportable claims. Raw Codonopsis is not structurally scarce relative to the volume required by the supplement market, but manufacturers still face agricultural variability, botanical identity control, contaminants, extraction differences and batch consistency requirements. Quality execution is becoming more important as regulators strengthen manufacturing and traceability expectations. China’s GB 17405—2025 Good Manufacturing Practice standard for health foods strengthened requirements covering raw materials, process control, verification, testing, recalls and traceability. At the same time, the market must compete for consumer attention against more recognized botanical ingredients. The long-term challenge is therefore not simply securing root supply; it is demonstrating reliable sourcing, standardized processing, appropriate evidence and differentiated product positioning at a cost that remains commercially attractive.
Industry Chain Analysis
The industry chain begins with Codonopsis cultivation and primary herbal-material processing, followed by sorting, powder production, extraction or concentration, formulation, dosage-form manufacturing, finished-product packaging, brand ownership and downstream distribution. Finished products may be produced by vertically integrated botanical companies or by specialist OEM, ODM and contract manufacturers. China is particularly important in upstream material availability and multi-format manufacturing, while North America and Europe contain a sizeable group of vertically integrated specialist botanical companies. The study scope focuses on finished consumer supplements, so intermediate raw roots, bulk powders and extracts are inputs to the market rather than market revenue themselves.
Value creation increasingly occurs after the raw-material stage. Producer ASP reflects extraction and formulation complexity, additional active ingredients, analytical testing, GMP manufacturing, packaging and brand and channel positioning rather than the cost of Codonopsis root alone. Professional and specialty channels can support higher-value formulations, whereas OEM and ODM models typically operate at lower producer realizations but benefit from production scale and lower consumer-acquisition requirements. China’s commissioned-production rules, effective from December 1, 2026, explicitly cover models including OEM and ODM and reinforce responsibility for both commissioning and manufacturing parties, increasing the strategic value of strong quality systems and traceability.
Segment Insights
Dosage form remains the clearest product segmentation. In 2025, Capsules and Softgels accounted for an estimated 32% of the market, followed by Oral Liquids, Tinctures and Drops at 24%, Tablets and Pills at 20.8%, and Powders, Granules and Sachets at 15.7%; measured beverages, gummies or chewables and other oral forms remained smaller. Capsules are expected to retain the largest position through 2032, while powders, granules and sachets gradually gain share. Gummies and related formats grow from a very small base and remain a product-development opportunity rather than a core market format. The approved dosage-form structure is consistent with the broad range of supplement forms recognized by FDA and with observed Codonopsis products across multiple markets.
Downstream Market Opportunities
The most attractive downstream opportunity is not a single demographic segment but the intersection of functional consumer demand and channel specialization. Consumer-facing brands can use Codonopsis in immune, vitality, fatigue-management and general-wellness formulas, while practitioner-focused companies can retain higher-value complex botanical formulations supported by professional recommendation. Sun Ten currently restricts its Dang Shen product to licensed practitioners with wholesale access, while Integria’s MediHerb range is designated practitioner-only in Australia and New Zealand, confirming that professional healthcare channels are a meaningful part of the commercial ecosystem rather than a niche distribution anomaly. At the same time, broader supplement-sector growth in e-commerce creates room for established botanical brands to reach consumers beyond traditional health-food stores. The strongest opportunities should therefore emerge where Codonopsis is integrated into a clearly defined health proposition, delivered in a convenient format and supported by the channel architecture appropriate for the product’s evidence and price position.
Regional Insights
China has the deepest combination of Codonopsis raw-material resources, traditional-use familiarity, regulated health-food activity and multi-format contract-manufacturing capabilities. Its competitive advantage is increasingly moving from simple raw-material access toward regulated product development, quality systems and OEM and ODM execution. North America is characterized by specialist botanical manufacturers, natural-health retail, direct-to-consumer activity and practitioner channels, making it a relatively high-value but ingredient-awareness-sensitive market. Europe supports a dispersed base of phytotherapy and traditional-formula manufacturers and a mature supplement-consumption environment, but regulatory and claims requirements remain less uniform for botanicals than for standardized vitamin and mineral supplements.
Asia-Pacific outside China is more differentiated: Taiwan provides a strong traditional-formula manufacturing base, Australia combines practitioner medicine with a developed complementary-medicines ecosystem, and several other countries remain more dependent on imports or have less confirmed local Codonopsis manufacturing. Other global regions currently show thinner domestic manufacturing depth and are more likely to develop first through importing, distribution and localized brand activity before building substantial Codonopsis-specific manufacturing ecosystems. These regional differences indicate that international expansion should be managed by regulatory route, channel structure and formula positioning rather than by applying a single global commercialization model.
Competitive Landscape Analysis
Competition is fragmented to moderately concentrated and spans several distinct business models. St. Francis Herb Farm and Sun Ten form the most defensible leading pair in the current competitive set: St. Francis Herb Farm combines a flagship Codonopsis-containing immune formula with dedicated botanical manufacturing, while Sun Ten combines single-herb and traditional multi-herb formulations with practitioner-oriented distribution. St. Francis Herb Farm continues to identify Deep Immune Capsules as its best-selling original formula, and Sun Ten currently restricts Dang Shen purchasing to licensed practitioners.
A broad specialist group—including Integria Healthcare, Threshold Enterprises, Soria Natural, Nature's Answer and Laboratoires JZ—competes through practitioner access, botanical extraction expertise, vertical integration, international distribution or traditional-formula specialization. Chinese participants such as Anhui Zhengxing, BYHEALTH and Tong Ren Tang bring a different competitive profile based on manufacturing scale, broad dosage-form capabilities, brand assets and regulated product portfolios. The resulting structure favors companies that can combine product relevance with manufacturing quality and channel reach; exact positions beyond the leading cluster should be interpreted more cautiously than the composition of the leading group itself.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Codonopsis Health Supplements market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
St. Francis Herb Farm
Sun Ten
Integria Healthcare
Threshold Enterprises
Soria Natural
Nature's Answer
Laboratoires JZ
Anhui Zhengxing
BYHEALTH
Tong Ren Tang
Kan Herb
T-Root
Biogroup
Zhongwei Hezhi
Herbalist & Alchemist
Hawaii Pharm
Hunan Yandi
Jinri Pharmaceutical
Dongsheng Ejiao
Tsuf Herbs
Energy Group
Dong'e Gujiao
Lurun Ejiao
Runshengtang Ejiao
Jiaocheng Ejiao
Yatai Yong'an Tang
Luoyang Zhongkang
Manufaktur Koch
TANQUE
Rosby Czech
Willow Wellness
Lijia Pharmaceutical
Laboratorio Asclepio
Erlingen
Yishengtang Ejiao
Segment by Type
Capsules and Softgels
Tablets and Pills
Powders, Granules and Sachets
Oral Liquids, Tinctures and Drops
Tea and Measured Beverage Formats
Gummies, Chewables and Confectionery Forms
Other Oral Forms
Segment by Formula Architecture
Single-Codonopsis Botanical Formulas
Multi-Botanical Formulas
Hybrid Multi-Ingredient Formulas
Segment by Application
Online Sales
Offline Sales
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Codonopsis Health Supplements study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Codonopsis Health Supplements: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Codonopsis Health Supplements Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Capsules and Softgels
1.2.3 Tablets and Pills
1.2.4 Powders, Granules and Sachets
1.2.5 Oral Liquids, Tinctures and Drops
1.2.6 Tea and Measured Beverage Formats
1.2.7 Gummies, Chewables and Confectionery Forms
1.2.8 Other Oral Forms
1.3 Market Segmentation by Formula Architecture
1.3.1 Global Codonopsis Health Supplements Market Size by Formula Architecture, 2021 vs 2025 vs 2032
1.3.2 Single-Codonopsis Botanical Formulas
1.3.3 Multi-Botanical Formulas
1.3.4 Hybrid Multi-Ingredient Formulas
1.4 Market Segmentation by Application
1.4.1 Global Codonopsis Health Supplements Market Size by Application, 2021 vs 2025 vs 2032
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Codonopsis Health Supplements Revenue Estimates and Forecasts (2021-2032)
2.2 Global Codonopsis Health Supplements Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Codonopsis Health Supplements Sales Estimates and Forecasts (2021-2032)
2.4 Global Codonopsis Health Supplements Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Codonopsis Health Supplements Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Codonopsis Health Supplements Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Capsules and Softgels: Market Share by Key Manufacturers
3.5.2 Tablets and Pills: Market Share by Key Manufacturers
3.5.3 Powders, Granules and Sachets: Market Share by Key Manufacturers
3.5.4 Oral Liquids, Tinctures and Drops: Market Share by Key Manufacturers
3.5.5 Tea and Measured Beverage Formats: Market Share by Key Manufacturers
3.5.6 Gummies, Chewables and Confectionery Forms: Market Share by Key Manufacturers
3.5.7 Other Oral Forms: Market Share by Key Manufacturers
3.6 Global Codonopsis Health Supplements Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Codonopsis Health Supplements Sales Performance by Type
4.1.1 Global Codonopsis Health Supplements Sales Volume by Type (2021-2032)
4.1.2 Global Codonopsis Health Supplements Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Codonopsis Health Supplements Sales Performance by Formula Architecture
4.2.1 Global Codonopsis Health Supplements Sales Volume by Formula Architecture (2021-2032)
4.2.2 Global Codonopsis Health Supplements Revenue by Formula Architecture (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Formula Architecture (2021-2032)
4.3 Product Technology Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Codonopsis Health Supplements Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Codonopsis Health Supplements Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Codonopsis Health Supplements Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Codonopsis Health Supplements Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Codonopsis Health Supplements Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Codonopsis Health Supplements Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Codonopsis Health Supplements Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Codonopsis Health Supplements Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Codonopsis Health Supplements Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Codonopsis Health Supplements Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Codonopsis Health Supplements Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Codonopsis Health Supplements Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 St. Francis Herb Farm
11.1.1 St. Francis Herb Farm Corporation Information
11.1.2 St. Francis Herb Farm Business Overview
11.1.3 St. Francis Herb Farm Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.1.4 St. Francis Herb Farm Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 St. Francis Herb Farm Codonopsis Health Supplements Sales by Product in 2025
11.1.6 St. Francis Herb Farm Codonopsis Health Supplements Sales by Application in 2025
11.1.7 St. Francis Herb Farm Codonopsis Health Supplements Sales by Geographic Area in 2025
11.1.8 St. Francis Herb Farm Codonopsis Health Supplements SWOT Analysis
11.1.9 St. Francis Herb Farm Recent Developments
11.2 Sun Ten
11.2.1 Sun Ten Corporation Information
11.2.2 Sun Ten Business Overview
11.2.3 Sun Ten Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.2.4 Sun Ten Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Sun Ten Codonopsis Health Supplements Sales by Product in 2025
11.2.6 Sun Ten Codonopsis Health Supplements Sales by Application in 2025
11.2.7 Sun Ten Codonopsis Health Supplements Sales by Geographic Area in 2025
11.2.8 Sun Ten Codonopsis Health Supplements SWOT Analysis
11.2.9 Sun Ten Recent Developments
11.3 Integria Healthcare
11.3.1 Integria Healthcare Corporation Information
11.3.2 Integria Healthcare Business Overview
11.3.3 Integria Healthcare Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.3.4 Integria Healthcare Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Integria Healthcare Codonopsis Health Supplements Sales by Product in 2025
11.3.6 Integria Healthcare Codonopsis Health Supplements Sales by Application in 2025
11.3.7 Integria Healthcare Codonopsis Health Supplements Sales by Geographic Area in 2025
11.3.8 Integria Healthcare Codonopsis Health Supplements SWOT Analysis
11.3.9 Integria Healthcare Recent Developments
11.4 Threshold Enterprises
11.4.1 Threshold Enterprises Corporation Information
11.4.2 Threshold Enterprises Business Overview
11.4.3 Threshold Enterprises Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.4.4 Threshold Enterprises Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Threshold Enterprises Codonopsis Health Supplements Sales by Product in 2025
11.4.6 Threshold Enterprises Codonopsis Health Supplements Sales by Application in 2025
11.4.7 Threshold Enterprises Codonopsis Health Supplements Sales by Geographic Area in 2025
11.4.8 Threshold Enterprises Codonopsis Health Supplements SWOT Analysis
11.4.9 Threshold Enterprises Recent Developments
11.5 Soria Natural
11.5.1 Soria Natural Corporation Information
11.5.2 Soria Natural Business Overview
11.5.3 Soria Natural Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.5.4 Soria Natural Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Soria Natural Codonopsis Health Supplements Sales by Product in 2025
11.5.6 Soria Natural Codonopsis Health Supplements Sales by Application in 2025
11.5.7 Soria Natural Codonopsis Health Supplements Sales by Geographic Area in 2025
11.5.8 Soria Natural Codonopsis Health Supplements SWOT Analysis
11.5.9 Soria Natural Recent Developments
11.6 Nature's Answer
11.6.1 Nature's Answer Corporation Information
11.6.2 Nature's Answer Business Overview
11.6.3 Nature's Answer Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.6.4 Nature's Answer Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Nature's Answer Recent Developments
11.7 Laboratoires JZ
11.7.1 Laboratoires JZ Corporation Information
11.7.2 Laboratoires JZ Business Overview
11.7.3 Laboratoires JZ Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.7.4 Laboratoires JZ Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Laboratoires JZ Recent Developments
11.8 Anhui Zhengxing
11.8.1 Anhui Zhengxing Corporation Information
11.8.2 Anhui Zhengxing Business Overview
11.8.3 Anhui Zhengxing Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.8.4 Anhui Zhengxing Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Anhui Zhengxing Recent Developments
11.9 BYHEALTH
11.9.1 BYHEALTH Corporation Information
11.9.2 BYHEALTH Business Overview
11.9.3 BYHEALTH Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.9.4 BYHEALTH Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 BYHEALTH Recent Developments
11.10 Tong Ren Tang
11.10.1 Tong Ren Tang Corporation Information
11.10.2 Tong Ren Tang Business Overview
11.10.3 Tong Ren Tang Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.10.4 Tong Ren Tang Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Tong Ren Tang Recent Developments
11.11 Kan Herb
11.11.1 Kan Herb Corporation Information
11.11.2 Kan Herb Business Overview
11.11.3 Kan Herb Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.11.4 Kan Herb Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Kan Herb Recent Developments
11.12 T-Root
11.12.1 T-Root Corporation Information
11.12.2 T-Root Business Overview
11.12.3 T-Root Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.12.4 T-Root Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 T-Root Recent Developments
11.13 Biogroup
11.13.1 Biogroup Corporation Information
11.13.2 Biogroup Business Overview
11.13.3 Biogroup Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.13.4 Biogroup Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Biogroup Recent Developments
11.14 Zhongwei Hezhi
11.14.1 Zhongwei Hezhi Corporation Information
11.14.2 Zhongwei Hezhi Business Overview
11.14.3 Zhongwei Hezhi Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.14.4 Zhongwei Hezhi Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Zhongwei Hezhi Recent Developments
11.15 Herbalist & Alchemist
11.15.1 Herbalist & Alchemist Corporation Information
11.15.2 Herbalist & Alchemist Business Overview
11.15.3 Herbalist & Alchemist Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.15.4 Herbalist & Alchemist Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Herbalist & Alchemist Recent Developments
11.16 Hawaii Pharm
11.16.1 Hawaii Pharm Corporation Information
11.16.2 Hawaii Pharm Business Overview
11.16.3 Hawaii Pharm Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.16.4 Hawaii Pharm Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Hawaii Pharm Recent Developments
11.17 Hunan Yandi
11.17.1 Hunan Yandi Corporation Information
11.17.2 Hunan Yandi Business Overview
11.17.3 Hunan Yandi Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.17.4 Hunan Yandi Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Hunan Yandi Recent Developments
11.18 Jinri Pharmaceutical
11.18.1 Jinri Pharmaceutical Corporation Information
11.18.2 Jinri Pharmaceutical Business Overview
11.18.3 Jinri Pharmaceutical Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.18.4 Jinri Pharmaceutical Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Jinri Pharmaceutical Recent Developments
11.19 Dongsheng Ejiao
11.19.1 Dongsheng Ejiao Corporation Information
11.19.2 Dongsheng Ejiao Business Overview
11.19.3 Dongsheng Ejiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.19.4 Dongsheng Ejiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Dongsheng Ejiao Recent Developments
11.20 Tsuf Herbs
11.20.1 Tsuf Herbs Corporation Information
11.20.2 Tsuf Herbs Business Overview
11.20.3 Tsuf Herbs Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.20.4 Tsuf Herbs Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Tsuf Herbs Recent Developments
11.21 Energy Group
11.21.1 Energy Group Corporation Information
11.21.2 Energy Group Business Overview
11.21.3 Energy Group Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.21.4 Energy Group Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Energy Group Recent Developments
11.22 Dong'e Gujiao
11.22.1 Dong'e Gujiao Corporation Information
11.22.2 Dong'e Gujiao Business Overview
11.22.3 Dong'e Gujiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.22.4 Dong'e Gujiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Dong'e Gujiao Recent Developments
11.23 Lurun Ejiao
11.23.1 Lurun Ejiao Corporation Information
11.23.2 Lurun Ejiao Business Overview
11.23.3 Lurun Ejiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.23.4 Lurun Ejiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Lurun Ejiao Recent Developments
11.24 Runshengtang Ejiao
11.24.1 Runshengtang Ejiao Corporation Information
11.24.2 Runshengtang Ejiao Business Overview
11.24.3 Runshengtang Ejiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.24.4 Runshengtang Ejiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Runshengtang Ejiao Recent Developments
11.25 Jiaocheng Ejiao
11.25.1 Jiaocheng Ejiao Corporation Information
11.25.2 Jiaocheng Ejiao Business Overview
11.25.3 Jiaocheng Ejiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.25.4 Jiaocheng Ejiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Jiaocheng Ejiao Recent Developments
11.26 Yatai Yong'an Tang
11.26.1 Yatai Yong'an Tang Corporation Information
11.26.2 Yatai Yong'an Tang Business Overview
11.26.3 Yatai Yong'an Tang Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.26.4 Yatai Yong'an Tang Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Yatai Yong'an Tang Recent Developments
11.27 Luoyang Zhongkang
11.27.1 Luoyang Zhongkang Corporation Information
11.27.2 Luoyang Zhongkang Business Overview
11.27.3 Luoyang Zhongkang Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.27.4 Luoyang Zhongkang Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Luoyang Zhongkang Recent Developments
11.28 Manufaktur Koch
11.28.1 Manufaktur Koch Corporation Information
11.28.2 Manufaktur Koch Business Overview
11.28.3 Manufaktur Koch Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.28.4 Manufaktur Koch Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 Manufaktur Koch Recent Developments
11.29 TANQUE
11.29.1 TANQUE Corporation Information
11.29.2 TANQUE Business Overview
11.29.3 TANQUE Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.29.4 TANQUE Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.29.5 TANQUE Recent Developments
11.30 Rosby Czech
11.30.1 Rosby Czech Corporation Information
11.30.2 Rosby Czech Business Overview
11.30.3 Rosby Czech Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.30.4 Rosby Czech Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.30.5 Rosby Czech Recent Developments
11.31 Willow Wellness
11.31.1 Willow Wellness Corporation Information
11.31.2 Willow Wellness Business Overview
11.31.3 Willow Wellness Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.31.4 Willow Wellness Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.31.5 Willow Wellness Recent Developments
11.32 Lijia Pharmaceutical
11.32.1 Lijia Pharmaceutical Corporation Information
11.32.2 Lijia Pharmaceutical Business Overview
11.32.3 Lijia Pharmaceutical Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.32.4 Lijia Pharmaceutical Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.32.5 Lijia Pharmaceutical Recent Developments
11.33 Laboratorio Asclepio
11.33.1 Laboratorio Asclepio Corporation Information
11.33.2 Laboratorio Asclepio Business Overview
11.33.3 Laboratorio Asclepio Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.33.4 Laboratorio Asclepio Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.33.5 Laboratorio Asclepio Recent Developments
11.34 Erlingen
11.34.1 Erlingen Corporation Information
11.34.2 Erlingen Business Overview
11.34.3 Erlingen Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.34.4 Erlingen Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.34.5 Erlingen Recent Developments
11.35 Yishengtang Ejiao
11.35.1 Yishengtang Ejiao Corporation Information
11.35.2 Yishengtang Ejiao Business Overview
11.35.3 Yishengtang Ejiao Codonopsis Health Supplements Product Models, Descriptions and Specifications
11.35.4 Yishengtang Ejiao Codonopsis Health Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
11.35.5 Yishengtang Ejiao Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Codonopsis Health Supplements Industry Chain
12.2 Codonopsis Health Supplements Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Codonopsis Health Supplements Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Codonopsis Health Supplements Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Codonopsis Health Supplements Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Codonopsis Health Supplements Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Codonopsis Health Supplements Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Codonopsis Health Supplements Market Size Growth Rate by Formula Architecture, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Codonopsis Health Supplements Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Codonopsis Health Supplements Revenue by Region (US$ Million), 2021-2026
Table 6. Global Codonopsis Health Supplements Revenue by Region (US$ Million), 2027-2032
Table 7. Global Codonopsis Health Supplements Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 8. Global Codonopsis Health Supplements Sales by Region (K Units), 2021-2026
Table 9. Global Codonopsis Health Supplements Sales by Region (K Units), 2027-2032
Table 10. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 11. Global Codonopsis Health Supplements Sales by Manufacturers (K Units), 2021-2026
Table 12. Global Codonopsis Health Supplements Sales Share by Manufacturers (2021-2026)
Table 13. Global Codonopsis Health Supplements Revenue by Manufacturers (US$ Million), 2021-2026
Table 14. Global Codonopsis Health Supplements Revenue-Based Market Share by Manufacturers (2021-2026)
Table 15. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 16. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Codonopsis Health Supplements Revenue, 2025
Table 17. Global Codonopsis Health Supplements Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 18. Global Codonopsis Health Supplements Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 19. Key Manufacturers Codonopsis Health Supplements Manufacturing Base and Headquarters
Table 20. Global Codonopsis Health Supplements Market Concentration Ratio (CR5)
Table 21. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 22. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 23. Global Codonopsis Health Supplements Sales Volume by Type (K Units), 2021-2026
Table 24. Global Codonopsis Health Supplements Sales Volume by Type (K Units), 2027-2032
Table 25. Global Codonopsis Health Supplements Revenue by Type (US$ Million), 2021-2026
Table 26. Global Codonopsis Health Supplements Revenue by Type (US$ Million), 2027-2032
Table 27. Global Codonopsis Health Supplements Sales Volume by Formula Architecture (K Units), 2021-2026
Table 28. Global Codonopsis Health Supplements Sales Volume by Formula Architecture (K Units), 2027-2032
Table 29. Global Codonopsis Health Supplements Revenue by Formula Architecture (US$ Million), 2021-2026
Table 30. Global Codonopsis Health Supplements Revenue by Formula Architecture (US$ Million), 2027-2032
Table 31. Technical Specifications by Key Product Type
Table 32. Global Codonopsis Health Supplements Sales by Application (K Units), 2021-2026
Table 33. Global Codonopsis Health Supplements Sales by Application (K Units), 2027-2032
Table 34. Codonopsis Health Supplements High-Growth Sectors Demand CAGR (2026-2032)
Table 35. Global Codonopsis Health Supplements Revenue by Application (US$ Million), 2021-2026
Table 36. Global Codonopsis Health Supplements Revenue by Application (US$ Million), 2027-2032
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Codonopsis Health Supplements Growth Accelerators and Market Barriers
Table 40. North America Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 41. North America Codonopsis Health Supplements Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Europe Codonopsis Health Supplements Growth Accelerators and Market Barriers
Table 43. Europe Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Europe Codonopsis Health Supplements Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 45. Asia-Pacific Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Asia-Pacific Codonopsis Health Supplements Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Asia-Pacific Codonopsis Health Supplements Growth Accelerators and Market Barriers
Table 48. Southeast Asia Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Central and South America Codonopsis Health Supplements Investment Opportunities and Key Challenges
Table 50. Central and South America Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. Middle East and Africa Codonopsis Health Supplements Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Codonopsis Health Supplements Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 53. St. Francis Herb Farm Corporation Information
Table 54. St. Francis Herb Farm Description and Major Businesses
Table 55. St. Francis Herb Farm Product Models, Descriptions and Specifications
Table 56. St. Francis Herb Farm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 57. St. Francis Herb Farm Sales Value Proportion by Product in 2025
Table 58. St. Francis Herb Farm Sales Value Proportion by Application in 2025
Table 59. St. Francis Herb Farm Sales Value Proportion by Geographic Area in 2025
Table 60. St. Francis Herb Farm Codonopsis Health Supplements SWOT Analysis
Table 61. St. Francis Herb Farm Recent Developments
Table 62. Sun Ten Corporation Information
Table 63. Sun Ten Description and Major Businesses
Table 64. Sun Ten Product Models, Descriptions and Specifications
Table 65. Sun Ten Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Sun Ten Sales Value Proportion by Product in 2025
Table 67. Sun Ten Sales Value Proportion by Application in 2025
Table 68. Sun Ten Sales Value Proportion by Geographic Area in 2025
Table 69. Sun Ten Codonopsis Health Supplements SWOT Analysis
Table 70. Sun Ten Recent Developments
Table 71. Integria Healthcare Corporation Information
Table 72. Integria Healthcare Description and Major Businesses
Table 73. Integria Healthcare Product Models, Descriptions and Specifications
Table 74. Integria Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Integria Healthcare Sales Value Proportion by Product in 2025
Table 76. Integria Healthcare Sales Value Proportion by Application in 2025
Table 77. Integria Healthcare Sales Value Proportion by Geographic Area in 2025
Table 78. Integria Healthcare Codonopsis Health Supplements SWOT Analysis
Table 79. Integria Healthcare Recent Developments
Table 80. Threshold Enterprises Corporation Information
Table 81. Threshold Enterprises Description and Major Businesses
Table 82. Threshold Enterprises Product Models, Descriptions and Specifications
Table 83. Threshold Enterprises Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Threshold Enterprises Sales Value Proportion by Product in 2025
Table 85. Threshold Enterprises Sales Value Proportion by Application in 2025
Table 86. Threshold Enterprises Sales Value Proportion by Geographic Area in 2025
Table 87. Threshold Enterprises Codonopsis Health Supplements SWOT Analysis
Table 88. Threshold Enterprises Recent Developments
Table 89. Soria Natural Corporation Information
Table 90. Soria Natural Description and Major Businesses
Table 91. Soria Natural Product Models, Descriptions and Specifications
Table 92. Soria Natural Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Soria Natural Sales Value Proportion by Product in 2025
Table 94. Soria Natural Sales Value Proportion by Application in 2025
Table 95. Soria Natural Sales Value Proportion by Geographic Area in 2025
Table 96. Soria Natural Codonopsis Health Supplements SWOT Analysis
Table 97. Soria Natural Recent Developments
Table 98. Nature's Answer Corporation Information
Table 99. Nature's Answer Description and Major Businesses
Table 100. Nature's Answer Product Models, Descriptions and Specifications
Table 101. Nature's Answer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Nature's Answer Recent Developments
Table 103. Laboratoires JZ Corporation Information
Table 104. Laboratoires JZ Description and Major Businesses
Table 105. Laboratoires JZ Product Models, Descriptions and Specifications
Table 106. Laboratoires JZ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Laboratoires JZ Recent Developments
Table 108. Anhui Zhengxing Corporation Information
Table 109. Anhui Zhengxing Description and Major Businesses
Table 110. Anhui Zhengxing Product Models, Descriptions and Specifications
Table 111. Anhui Zhengxing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Anhui Zhengxing Recent Developments
Table 113. BYHEALTH Corporation Information
Table 114. BYHEALTH Description and Major Businesses
Table 115. BYHEALTH Product Models, Descriptions and Specifications
Table 116. BYHEALTH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. BYHEALTH Recent Developments
Table 118. Tong Ren Tang Corporation Information
Table 119. Tong Ren Tang Description and Major Businesses
Table 120. Tong Ren Tang Product Models, Descriptions and Specifications
Table 121. Tong Ren Tang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Tong Ren Tang Recent Developments
Table 123. Kan Herb Corporation Information
Table 124. Kan Herb Description and Major Businesses
Table 125. Kan Herb Product Models, Descriptions and Specifications
Table 126. Kan Herb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Kan Herb Recent Developments
Table 128. T-Root Corporation Information
Table 129. T-Root Description and Major Businesses
Table 130. T-Root Product Models, Descriptions and Specifications
Table 131. T-Root Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. T-Root Recent Developments
Table 133. Biogroup Corporation Information
Table 134. Biogroup Description and Major Businesses
Table 135. Biogroup Product Models, Descriptions and Specifications
Table 136. Biogroup Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Biogroup Recent Developments
Table 138. Zhongwei Hezhi Corporation Information
Table 139. Zhongwei Hezhi Description and Major Businesses
Table 140. Zhongwei Hezhi Product Models, Descriptions and Specifications
Table 141. Zhongwei Hezhi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Zhongwei Hezhi Recent Developments
Table 143. Herbalist & Alchemist Corporation Information
Table 144. Herbalist & Alchemist Description and Major Businesses
Table 145. Herbalist & Alchemist Product Models, Descriptions and Specifications
Table 146. Herbalist & Alchemist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Herbalist & Alchemist Recent Developments
Table 148. Hawaii Pharm Corporation Information
Table 149. Hawaii Pharm Description and Major Businesses
Table 150. Hawaii Pharm Product Models, Descriptions and Specifications
Table 151. Hawaii Pharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Hawaii Pharm Recent Developments
Table 153. Hunan Yandi Corporation Information
Table 154. Hunan Yandi Description and Major Businesses
Table 155. Hunan Yandi Product Models, Descriptions and Specifications
Table 156. Hunan Yandi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Hunan Yandi Recent Developments
Table 158. Jinri Pharmaceutical Corporation Information
Table 159. Jinri Pharmaceutical Description and Major Businesses
Table 160. Jinri Pharmaceutical Product Models, Descriptions and Specifications
Table 161. Jinri Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Jinri Pharmaceutical Recent Developments
Table 163. Dongsheng Ejiao Corporation Information
Table 164. Dongsheng Ejiao Description and Major Businesses
Table 165. Dongsheng Ejiao Product Models, Descriptions and Specifications
Table 166. Dongsheng Ejiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Dongsheng Ejiao Recent Developments
Table 168. Tsuf Herbs Corporation Information
Table 169. Tsuf Herbs Description and Major Businesses
Table 170. Tsuf Herbs Product Models, Descriptions and Specifications
Table 171. Tsuf Herbs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Tsuf Herbs Recent Developments
Table 173. Energy Group Corporation Information
Table 174. Energy Group Description and Major Businesses
Table 175. Energy Group Product Models, Descriptions and Specifications
Table 176. Energy Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Energy Group Recent Developments
Table 178. Dong'e Gujiao Corporation Information
Table 179. Dong'e Gujiao Description and Major Businesses
Table 180. Dong'e Gujiao Product Models, Descriptions and Specifications
Table 181. Dong'e Gujiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Dong'e Gujiao Recent Developments
Table 183. Lurun Ejiao Corporation Information
Table 184. Lurun Ejiao Description and Major Businesses
Table 185. Lurun Ejiao Product Models, Descriptions and Specifications
Table 186. Lurun Ejiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Lurun Ejiao Recent Developments
Table 188. Runshengtang Ejiao Corporation Information
Table 189. Runshengtang Ejiao Description and Major Businesses
Table 190. Runshengtang Ejiao Product Models, Descriptions and Specifications
Table 191. Runshengtang Ejiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Runshengtang Ejiao Recent Developments
Table 193. Jiaocheng Ejiao Corporation Information
Table 194. Jiaocheng Ejiao Description and Major Businesses
Table 195. Jiaocheng Ejiao Product Models, Descriptions and Specifications
Table 196. Jiaocheng Ejiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Jiaocheng Ejiao Recent Developments
Table 198. Yatai Yong'an Tang Corporation Information
Table 199. Yatai Yong'an Tang Description and Major Businesses
Table 200. Yatai Yong'an Tang Product Models, Descriptions and Specifications
Table 201. Yatai Yong'an Tang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Yatai Yong'an Tang Recent Developments
Table 203. Luoyang Zhongkang Corporation Information
Table 204. Luoyang Zhongkang Description and Major Businesses
Table 205. Luoyang Zhongkang Product Models, Descriptions and Specifications
Table 206. Luoyang Zhongkang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Luoyang Zhongkang Recent Developments
Table 208. Manufaktur Koch Corporation Information
Table 209. Manufaktur Koch Description and Major Businesses
Table 210. Manufaktur Koch Product Models, Descriptions and Specifications
Table 211. Manufaktur Koch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Manufaktur Koch Recent Developments
Table 213. TANQUE Corporation Information
Table 214. TANQUE Description and Major Businesses
Table 215. TANQUE Product Models, Descriptions and Specifications
Table 216. TANQUE Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. TANQUE Recent Developments
Table 218. Rosby Czech Corporation Information
Table 219. Rosby Czech Description and Major Businesses
Table 220. Rosby Czech Product Models, Descriptions and Specifications
Table 221. Rosby Czech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 222. Rosby Czech Recent Developments
Table 223. Willow Wellness Corporation Information
Table 224. Willow Wellness Description and Major Businesses
Table 225. Willow Wellness Product Models, Descriptions and Specifications
Table 226. Willow Wellness Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 227. Willow Wellness Recent Developments
Table 228. Lijia Pharmaceutical Corporation Information
Table 229. Lijia Pharmaceutical Description and Major Businesses
Table 230. Lijia Pharmaceutical Product Models, Descriptions and Specifications
Table 231. Lijia Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 232. Lijia Pharmaceutical Recent Developments
Table 233. Laboratorio Asclepio Corporation Information
Table 234. Laboratorio Asclepio Description and Major Businesses
Table 235. Laboratorio Asclepio Product Models, Descriptions and Specifications
Table 236. Laboratorio Asclepio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 237. Laboratorio Asclepio Recent Developments
Table 238. Erlingen Corporation Information
Table 239. Erlingen Description and Major Businesses
Table 240. Erlingen Product Models, Descriptions and Specifications
Table 241. Erlingen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 242. Erlingen Recent Developments
Table 243. Yishengtang Ejiao Corporation Information
Table 244. Yishengtang Ejiao Description and Major Businesses
Table 245. Yishengtang Ejiao Product Models, Descriptions and Specifications
Table 246. Yishengtang Ejiao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 247. Yishengtang Ejiao Recent Developments
Table 248. Key Raw Materials Distribution
Table 249. Raw Materials Key Suppliers
Table 250. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 251. Milestones in Production Technology Evolution
Table 252. Distributors List
Table 253. Market Trends and Market Evolution
Table 254. Market Drivers and Opportunities
Table 255. Market Challenges, Risks, and Restraints
Table 256. Research Programs/Design for This Report
Table 257. Key Data Information from Secondary Sources
Table 258. Key Data Information from Primary Sources

List of Figures
Figure 1. Codonopsis Health Supplements Product Picture
Figure 2. Global Codonopsis Health Supplements Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Capsules and Softgels Product Picture
Figure 4. Tablets and Pills Product Picture
Figure 5. Powders, Granules and Sachets Product Picture
Figure 6. Oral Liquids, Tinctures and Drops Product Picture
Figure 7. Tea and Measured Beverage Formats Product Picture
Figure 8. Gummies, Chewables and Confectionery Forms Product Picture
Figure 9. Other Oral Forms Product Picture
Figure 10. Global Codonopsis Health Supplements Market Size Growth Rate by Formula Architecture, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Single-Codonopsis Botanical Formulas Product Picture
Figure 12. Multi-Botanical Formulas Product Picture
Figure 13. Hybrid Multi-Ingredient Formulas Product Picture
Figure 14. Global Codonopsis Health Supplements Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Online Sales
Figure 16. Offline Sales
Figure 17. Codonopsis Health Supplements Report Years Considered
Figure 18. Global Codonopsis Health Supplements Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 20. Global Codonopsis Health Supplements Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Codonopsis Health Supplements Revenue-Based Market Share by Region (2021-2032)
Figure 22. Global Codonopsis Health Supplements Sales (K Units), 2021-2032
Figure 23. Global Codonopsis Health Supplements Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 24. Global Codonopsis Health Supplements Sales Market Share by Region (2021-2032)
Figure 25. Top 5 and Top 10 Manufacturers Codonopsis Health Supplements Sales Volume Market Share in 2025
Figure 26. Global Codonopsis Health Supplements Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Capsules and Softgels Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Tablets and Pills Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Powders, Granules and Sachets Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Oral Liquids, Tinctures and Drops Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Tea and Measured Beverage Formats Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Gummies, Chewables and Confectionery Forms Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Other Oral Forms Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Global Codonopsis Health Supplements Sales Volume-Based Market Share by Type (2021-2032)
Figure 36. Global Codonopsis Health Supplements Revenue-Based Market Share by Type (2021-2032)
Figure 37. Global Codonopsis Health Supplements ASP by Type (US$/Unit), 2021-2032
Figure 38. Global Codonopsis Health Supplements Sales Volume-Based Market Share by Formula Architecture (2021-2032)
Figure 39. Global Codonopsis Health Supplements Revenue-Based Market Share by Formula Architecture (2021-2032)
Figure 40. Global Codonopsis Health Supplements ASP by Formula Architecture (US$/Unit), 2021-2032
Figure 41. Global Codonopsis Health Supplements Revenue-Based Market Share (2021-2032)
Figure 42. Global Codonopsis Health Supplements Sales Market Share by Application (2021-2032)
Figure 43. Global Codonopsis Health Supplements Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Codonopsis Health Supplements ASP by Application (US$/Unit), 2021-2032
Figure 45. North America Codonopsis Health Supplements Sales YoY (K Units), 2021-2032
Figure 46. North America Codonopsis Health Supplements Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Codonopsis Health Supplements Sales Revenue (US$ Million) in 2025
Figure 48. North America Codonopsis Health Supplements Sales Volume (K Units) by Application (2021-2032)
Figure 49. North America Codonopsis Health Supplements Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 51. Canada Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 52. Mexico Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 53. Europe Codonopsis Health Supplements Sales YoY (K Units), 2021-2032
Figure 54. Europe Codonopsis Health Supplements Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Codonopsis Health Supplements Sales Revenue (US$ Million) in 2025
Figure 56. Europe Codonopsis Health Supplements Sales Volume (K Units) by Application (2021-2032)
Figure 57. Europe Codonopsis Health Supplements Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 59. France Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 60. U.K. Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 61. Italy Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 62. Russia Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Codonopsis Health Supplements Sales YoY (K Units), 2021-2032
Figure 64. Asia-Pacific Codonopsis Health Supplements Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Codonopsis Health Supplements Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Codonopsis Health Supplements Sales Volume (K Units) by Application (2021-2032)
Figure 67. Asia-Pacific Codonopsis Health Supplements Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 69. Japan Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 70. South Korea Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 72. India Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Codonopsis Health Supplements Sales YoY (K Units), 2021-2032
Figure 74. Central and South America Codonopsis Health Supplements Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Codonopsis Health Supplements Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Codonopsis Health Supplements Sales Volume (K Units) by Application (2021-2032)
Figure 77. Central and South America Codonopsis Health Supplements Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 79. Argentina Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Codonopsis Health Supplements Sales YoY (K Units), 2021-2032
Figure 81. Middle East and Africa Codonopsis Health Supplements Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Codonopsis Health Supplements Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Codonopsis Health Supplements Sales Volume (K Units) by Application (2021-2032)
Figure 84. Middle East and Africa Codonopsis Health Supplements Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 86. Turkey Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 87. Egypt Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 88. South Africa Codonopsis Health Supplements Revenue (US$ Million), 2021-2032
Figure 89. Codonopsis Health Supplements Industry Chain Mapping
Figure 90. Regional Codonopsis Health Supplements Manufacturing Base Distribution (%)
Figure 91. Global Codonopsis Health Supplements Production Market Share by Region (2021-2032)
Figure 92. Codonopsis Health Supplements Production Process
Figure 93. Regional Codonopsis Health Supplements Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed